baber/WOPTO huggingface dataset:
Patent NZ-588050-A (NZ)
Title: Recording dose information about ionizing radiation absored and stored in a dosimeter
Inventor: WILLIAMS GRANT VICTOR MCLELLAND
IPC: G01T1/115
Filed: 2010-09-17
Abstract: Disclosed is a radiation dosimeter detection system for recording dose information about ionizing radiation which is absorbed and stored in one or more dosimeters (14) located in an environment exposed to a radiation source(s). The system includes at least one dosimeter (14) with a phosphor-doped fluoroperovskite compound that is configured to absorb radiation from the environment within which it is located. The dosimeter (14) is optically coupled to a detector (12) by an optical fibre (34d). The detector (12) has a first optical stimulation source (20a) that is operable to emit stimulating light over the optical fibre (34d) to the dosimeter (14) at a wavelength(s) in a first wavelength range, and a second optical stimulation source (20b) that is operable to emit stimulating light over the optical fibre (34d) to the dosimeter (14) at a wavelength(s) in a second wavelength range. An optical detector is configured to receive and sense light emitted from the dosimeter (14) over the optical fibre (34b) and which, in response generates light detection signals (42), represents the dose information stored in the dosimeter (14). A control system is configured to read out the dose information by processing the light detection signals (42) from the optical detector and outputting the dose information, and is operable or configured to selectively control either or both of the first or second optical stimulation sources (20a, 20b) so as to selectively read-out the dose information.
Patent NZ-588409-A (NZ)
Title: Receiving a programming file and running a new security function program based on the file
Inventor: HAMMADOU TARIK
IPC: H04N5/225
Filed: 2006-04-12
Abstract: A method for configuring installed security systems and a system for configuring sensoring systems is disclosed. The system comprises at least one configurable device in an installed security system, that receives at least one device programming file, and a system manager. The configurable device is operable to perform a plurality of security functions where the plurality of security functions are associated with a plurality of video analytic and/or video processing applications. The video analytic and/or video processing applications comprises an application for analyzing behaviour occurring in the field of view of the at least one configurable device, and for determining whether the behaviour comprises a security anomaly. The system manager programs the configurable device to add a new security function associated with a new video analytic application to the configurable device where the programming is based on the received at least one device programming file.
Patent NZ-590456-A (NZ)
Title: Novel substituted sulfamide derivatives
Inventor: MCCOMSEY DAVID F
IPC: A61K31/357
Filed: 2009-07-15
Abstract: Provided is a sulphonamide derivative of Formula (I), where R1 is C1-4alkyl. The compounds are useful in treating various anxiety and related disorders, migraine, obesity, pain and substance abuse, among others. Further provided are methods of synthesizing the compounds.
Patent NZ-592802-A (NZ)
Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Inventor: BRUNCKO MILAN
IPC: A61K31/496
Filed: 2009-12-04
Abstract: 592802 Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. Compounds of the present disclosure include: 2-[(6-amino-5-chloropyridin-3-yl)oxy]-4-(4-{ [2-(4-chlorophenyl)-4,4-dimethylcyclohex-l-en-l-yl]methyl} piperazin-l-yl)-N-({ 3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl} sulfonyl)benzamide, N-({ 5-chloro-6-[(4,4-difluorocyclohexyl)methoxy]pyridin-3-yl} sulfonyl)-4-(4-{ [4-(4-chlorophenyl)-6,6-dimethyl-5,6-dihydro-2H-pyran-3-yl]methyl} piperazin-1-yl)-2-[(6-fluoro-1H-indol-5-yl)oxy]benzamide, 4-(4-{ [2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-5 yl]methyl} piperazin-1-yl)-N-({ 3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl} sulfonyl)-2-[2-(1H-pyrazol-4-yl)phenoxy]benzamide, Trans-2-[(6-amino-5-chloropyridin-3-yl)oxy]-4-(4-{ [2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl} piperazin-1-yl)-N-[(4-{ [(4-cyanocyclohexyl)methyl]amino} -3-nitrophenyl)sulfonyl]benzamide, 2-[(2-amino-5-bromopyridin-4-yl)oxy]-4-(4-{ [2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl} piperazin-1-yl)-N-({ 3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl} sulfonyl)benzamide, N-({ 5-chloro-6-[(4-fluorotetrahydro-2H-pyran-4-yl)methoxy]pyridin-3-yl} sulfonyl)-4-(4-{ [2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl} piperazin-1-yl)-2-[(6-fluoro-1H-indol-5-yl)oxy]benzamide, tert-butyl 4-(5-(4-{ [2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl} piperazin-1-yl)-2-{ [({ 3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl} sulfonyl)amino]carbonyl} phenoxy)pyridin-2-ylcarbamate and 2-(4-(acetylamino)phenoxy)-4-(4-((4'-chloro-1,1'-biphenyl-2-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)benzamide.
Patent NZ-593004-A (NZ)
Title: Azaazulene compounds
Inventor: LEE ON
IPC: A61K31/40
Filed: 2010-04-29
Abstract: 593004 Disclosed herein is an azaazulene compound of the formula (I) wherein the variables are defined in the specification, and the use thereof in the treatment of cancer. Specific embodiments of the compound include: 3-(benzimidazol-2-yl)-1-azaazulen-2-one, and 1-(N,N-dimethylaminobutan-4-yl)-3-[5-(4-methylpiperan-1-yl)-benzimidazol-2-yl]-1-azaazulen-2-one.
Patent NZ-593960-A (NZ)
Title: Phosphate fertilizers comprising elemental sulfur and cationic or amphoteric surfactants and process for the preparation thereof
Inventor: ANTENS JANY BIRGITTA MARIA
IPC: C05G3/70
Filed: 2010-01-29
Abstract: Disclosed is a process for the manufacture of sulphur-containing fertilizer compositions comprising the steps of: a) providing a slurry of at least one phosphate-based fertilizer material selected from the group consisting of ammonium phosphates, ammonium phosphate based nitrogen-phosphorus-potassium (NPK) compounds, super phosphates and partially acidulated phosphate rocks; b) bringing said slurry into contact with at least one cationic or amphoteric surfactant and a liquid phase of elemental sulphur; and c) introducing the mixture obtained in step b) into a granulator unit in order to obtain granules of the fertilizer composition Also disclosed is a fertilizer composition comprising: a) elemental sulfur, b) at least one phosphate-based fertilizer material selected from the group consisting of ammonium phosphates, ammonium phosphate based nitrogen-phosphorus-potassium compounds, super phosphates and partially acidulated phosphate rocks; and c) at least one cationic or amphoteric surfactant, wherein the cationic or amphoteric surfactant is dispersed throughout the fertilizer composition.
Patent NZ-595911-A (NZ)
Title: Method for installing and servicing an apparatus recovering the kinetic energy of water, and an apparatus recovering the kinetic energy of water
Inventor: KOIVUSAARI RAUNO
IPC: F03B13/18
Filed: 2010-03-24
Abstract: The object is a method for installing and servicing an apparatus module (1) recovering the kinetic energy of water; and the apparatus module (1) itself. The apparatus module (1) with wave energy recovering units (3) is descended into the sea bottom and is kept steady at the sea bottom by the help of its own mass and the mass of the water filled into compartments in the body (2) of the apparatus module (1). Correspondingly the apparatus module (1) is lifted into the surface of the water and made floating by the help of air that is blown to the compartments (2a) and (2c) in order to replace the water.
Patent NZ-597136-A (NZ)
Title: Novel conjugates, preparation thereof, and therapeutic use thereof
Inventor: BOUCHARD HERVE
IPC: A61P35/00
Filed: 2010-05-20
Abstract: 597136 The disclosure relates to a targeting agent, to which at least one cryptophycin is attached, of the formula (I), where: R1 is a halogen atom and R2 is an OH group, an acyl group derived from an amino acid AA or a (C1-C4)alkanoyloxy group; or else R1 and R2 together form an epoxy unit; AA denotes a natural or artificial amino acid; R3 is a (C1-C6)alkyl group; R4 and R5 are both H or together form a CH=CH double bond between C13 and C14; R6 and R7 are, independently from one another, H or a (C1-C6)alkyl group; R8 and R9 are, independently from one another, H or a (C1-C6)alkyl group; R10 is at least one substituent of the phenyl core selected from among: H, an OH group, (C1-C4)alkoxy, a halogen atom or a NH2, NH(C1-C6)alkyl, or N(C1-C6)alkyl group; R11 is at least one substituent of the phenyl core selected from among H or a (C1- C4)alkyl group; the targeting agent and the cryptophycin derivative being covalently bonded, the bond being located at the ortho (o), meta (m), or para (p) position of the phenyl core containing the CR1 unit. The conjugates of the disclosure are useful in the treatment of cancer.
Patent NZ-597178-A (NZ)
Title: Agent comprising Lactobacillus helveticus for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor
Inventor: KAWAKAMI HIROSHI
IPC: A61K35/747
Filed: 2007-08-30
Abstract: Provided is the use of cells or a culture of cells of Lactobacillus helveticus for the manufacture of a medicament for increasing blood adiponectin concentration or inhibiting a decrease in blood adiponectin concentration in a patient having a disease associated with abnormal blood adiponectin concentration or for treating/preventing metabolic syndrome or a disease associated with excessive visceral fat accumulation.
Patent NZ-598139-A (NZ)
Title: Controller for a power converter receiving input power and providing output power by a switching operation
Inventor: BROGAN PAUL BRIAN
IPC: G05B1/01
Filed: 2012-02-09
Abstract: Provided is a controller (116) for a converter (102) and a method of operating such a controller (116). The converter (102) receives an input power and provides an output power by a switching operation wherein the output power has at least two phases. The controller (116) comprises an input (118) for receiving a feedback signal (114) depending on the output power of the converter (102); and an output for providing a control signal (122) to the converter (102) to thereby control the switching operation of the converter (102). The control signal (122) corresponds to a switching pattern that is updated in response to the feedback signal (114). The control signal (122) includes a harmonic compensation signal (123) which reduces higher harmonics in the output power where the higher harmonics originate from a time delay between taking the feedback signal (114) and the updating of the switching pattern.
Patent NZ-603850-A (NZ)
Title: Plant disease control composition and its use
Inventor: MATSUZAKI YUICHI
IPC: A01N43/36
Filed: 2011-04-25
Abstract: Disclosed herein is a plant disease control composition comprising a carboxamide compound of formula (I), wherein R1 represents a hydrogen atom or methyl group, and R2 represents a methyl group, a difluoromethyl group or a trifluoromethyl group, and fludioxonil; and a method for controlling plant disease which comprises treating a plant, or soil where a plant grows, with an effective amount of said composition.
Patent NZ-607833-A (NZ)
Title: Apparatus and method for growing one or more plants
Inventor: DAAS TALAL
IPC: A01G31/02
Filed: 2010-10-29
Abstract: An apparatus 1 for growing one or more plants, comprises a first and a second chamber which are separated from each other by a first dividing wall 15. The second chamber is above the first chamber. The interior spaces of the first and the second chamber are connected by one or more connecting openings 16 in the first dividing wall 15, and the second chamber 20 includes one or more exit openings 26 which are arranged on a second dividing wall 25. The volume of at least one of the first chamber 10 and the second chamber 20 is variable. The first and second chambers are operative such that roots of the one or more plants are located in the first chamber 10, a crop part of the one or more plants is located in the second chamber 20 and a leaf canopy of the one or more plants is located above the second chamber 20.
Patent NZ-620132-A (NZ)
Title: Crowd-sourced video rendering system
Inventor: URBACH JULIAN MICHAEL
IPC: G06T15/50
Filed: 2012-08-09
Abstract: Disclosed is a method for graphic rendering over multiple clients (82, 84). The method includes distributing rendering tasks to connected client nodes (82, 84) having capable graphics processing units by transmitting viewport state data objects and a unique spatial location to each of the clients (82, 84); performing path tracing at each of the clients (82, 84) from the starting point of their unique spatial locations, and transmitting their rendered output back to the server (22). The server (22) generates a composite rendered output from the individual rendered outputs received by the participating clients (82, 84), and then transmits the composite to all connected clients (82, 84) for display. Thus, as the number of client nodes (82, 84) increases, the scene is rendered more rapidly and at higher quality.
Patent NZ-622583-A (NZ)
Title: Protein formulations and methods of making same
Inventor: KRAUSE HANS-JUERGEN
IPC: A61K38/02
Filed: 2008-11-28
Abstract: An aqueous pharmaceutical formulation consisting essentially of: (a) an anti-tumor necrosis factor alpha antibody such as adalimumab comprising a light chain variable region (LCVR) having a CDR3 domain comprising the amino acid sequence of SEQ ID NO:3, a CDR2 domain comprising the amino acid sequence of SEQ ID NO:5, and a CDR1 domain comprising the amino acid sequence of SEQ ID NO:7, and a heavy chain variable region (HCVR) having a CDR3 domain comprising the amino acid sequence of SEQ ID NO:4, a CDR2 domain comprising the amino acid sequence of SEQ ID NO:6, and a CDR1 domain comprising the amino acid sequence of SEQ ID NO:8, wherein the concentration of the antibody is 50 to 200 mg/ml; and (b) water. The disclosed formulations are substantially free of tonicity modifiers and buffers and are obtained by diafiltration.
Patent NZ-625870-A (NZ)
Title: Neutral, stable and transparent photocatalytic titanium dioxide sols
Inventor: KERROD JULIE ELIZABETH
IPC: C01G23/053
Filed: 2012-11-16
Abstract: Disclosed is a method for preparing a pH neutral titanium dioxide sol comprising (1) contacting a hydrous titanium dioxide gel with an alkaline peptizing agent (e.g., diethyl amine) to provide a peptized alkaline titanium dioxide sol; (2) neutralizing the peptized alkaline titanium dioxide sol with an acid (e.g., a mixture of phosphoric and acetic acid); and (3) obtaining or collecting the neutral, stable and transparent photocatalytic titanium dioxide sol. The titanium dioxide sol is stable and transparent over a range of pH of about 7.0 to about 9.5. The titanium dioxide sol may include crystallites of titanium dioxide having an average particle size of less than about 10 nm with at least 90% of the crystallites being in the anatase form.
Patent NZ-629475-A (NZ)
Title: Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
Inventor: KOLLAR MARK D
IPC: A61P25/06
Filed: 2013-09-27
Abstract: The present disclosure relates to intranasally administered pharmaceutical compositions for the treatment of headaches, such as migraines. Such pharmaceutical compositions comprise benzyl alcohol or a combination of benzyl alcohol and tetracaine. The disclosure also relates to methods for treating headaches, such as migraines, using these pharmaceutical compositions.
Patent NZ-709978-A (NZ)
Title: Method of insulating a building
Inventor: BEATTIE RONALD PETER
IPC: E04B1/76
Filed: 2014-02-07
Abstract: The invention relates to a method of thermally insulating a building which is capable of being applied to an existing building, to improve the overall level of thermal insulation of that building. The method is applied to a building that includes one or more existing external walls (2) and an existing roof structure (4) supported by the walls, and comprises constructing a first external shell structure (24a) that covers an outer surface of at least one external wall, said shell structure being spaced from the outer surface of the wall to provide a wall void (28) between the external wall and the shell structure. A second shell structure (24b) is constructed that extends around or through the existing roof structure (4) and provides an enclosed roof void (26b) that extends around or through the roof structure. The roof void (26b) is interconnected with the wall void (26a). The wall void (26a) and the roof void (26b) are filled with an insulating material to provide an insulating layer (28) that extends substantially continuously through the roof void and the wall void.
Patent NZ-719332-A (NZ)
Title: Electronic management of sleep related data
Inventor: LIU NATHAN ZERSEE
IPC: G16H15/00
Filed: 2014-10-24
Abstract: A system and method electronically manages sleep related data obtained by a diagnostic device. The system and method may include collecting sleep data from a patient using a diagnostic device. The sleep data may be stored in a sleep data file and delineated as multiple sleep sessions. A user may access the stored sleep data by selecting a particular sleep session. The sleep data for the selected sleep session may then be extracted from the sleep data file and presented to the user as a combination of image tiles, JavaScript elements, and an event indicator.
Patent NZ-724430-A (NZ)
Title: Slit-robo signaling for diagnosis and treatment of kidney disease
Inventor: LU WEINING
IPC: A61K38/17
Filed: 2013-01-04
Abstract: Disclosed is a pharmaceutical composition comprising a ROBO2 inhibitor, wherein the ROBO2 inhibitor is a soluble ROBO2 protein comprising a fusion polypeptide comprising both the Ig1 and Ig2 SLIT binding domains of ROBO2, with no intracellular ROBO2 domain. Also disclosed is the use of said composition in the treatment of chronic kidney disease or proteinuria.
Patent NZ-728420-A (NZ)
Title: Butt flare reducing apparatus for logs and related methods of reducing butt flare
Inventor: CHOLEWCZYNSKI MAREK
IPC: B27L1/08
Filed: 2015-07-23
Abstract: Butt flare reducing apparatuses are used to reshape the butt end of logs to remove the natural protruding root flares to provide a more consistent profile for further processing of the logs into other products. A butt flare reducing apparatus for logs is provided. The apparatus includes a machine frame, a stator ring assembly fixedly coupled to the machine frame, and a flare reducing tool adjustment assembly movably coupled to the stator ring assembly. The apparatus further includes an actuator coupled on one end to the machine frame and on the other end to the flare reducing tool adjustment assembly to move the flare reducing tool adjustment assembly between the opposing end positions, and a rotor assembly rotatably coupled to the stator ring assembly. The rotor assembly includes a rotor frame and at least one flare reducing tool movably coupled to the rotor frame to translate linearly toward and away from a longitudinal axis of rotation in direct correlation to movement of the actuator and flare reducing tool adjustment assembly to adjust a log processing diameter. Related methods are also provided. The butt flare reducing apparatus and related methods provide efficient, robust and reliable adjustment of log processing diameters before and/or during butt flare reducing operations.
Patent NZ-733762-A (NZ)
Title: A novel complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist
Inventor: DEROUAZI MADIHA
IPC: A61K39/00
Filed: 2016-03-16
Abstract: The present invention provides a novel complex comprising a) a cell penetrating peptide, b) at least one antigen or antigenic epitope, and c) at least one TLR peptide agonist, wherein the components a) - c) are covalently linked. Moreover, the present invention also provides a nucleic acid encoding such a complex, wherein the complex is a peptide or a protein. Such a nucleic acid may be comprised by a vector, and such a vector may be comprised by a host cell. In particular, compositions, such as a pharmaceutical compositions and vaccines are provided, which may be useful for example in the prevention and/or treatment of a diseases and/or a disorder including cancer, hematological disorders, infectious diseases, autoimmunity disorders and transplant rejections.
Patent NZ-738414-A (NZ)
Title: Liquid cartridge
Inventor: HIRANO MIKIO
IPC: B41J2/175
Filed: 2015-07-07
Abstract: A cartridge having a circuit board and the ink cartridge having an IC board, are problematic in that when the cartridge or ink cartridge is attached to the cartridge attaching unit or detached from it, the circuit board or the IC board slides on the contacts of the cartridge attaching unit and the conductive member of the circuit board or the IC board is cut away and shavings are thereby generated. If these shavings adhere to the optical sensor or to a portion detected by the sensor, detection by the sensor may become inaccurate. The present invention attempts to address the above problems by providing a liquid cartridge that less affects detection of a state of liquid stored in the liquid cartridge even if shavings are generated from a circuit board. An ink cartridge has a front surface, an upper surface facing an upward direction when the ink cartridge is installed in a printer, a liquid supply portion facing a first direction at the front surface, a circuit board disposed on the upper surface, and a liquid detection portion for detecting a state of liquid stored in the liquid cartridge. The liquid detection portion includes a light access portion configured to be accessed with light traveling from a first point toward a second point. The light access portion is disposed above the circuit board in the upward direction.
Patent NZ-741742-A (NZ)
Title: Prostate-associated antigens and vaccine-based immunotherapy regimens
Inventor: BINDER JOSEPH JOHN
IPC: A61K39/00
Filed: 2013-04-29
Abstract: The present disclosure provides a pharmaceutical product comprising (1) a vaccine comprising an antigen construct, and (2) a CTLA-4 inhibitor, wherein the antigen construct comprises a nucleotide sequence encoding an immunogenic PSMA polypeptide selected from the group consisting of: (i) a polypeptide consisting of amino acids 15-750 of the amino acid sequence of SEQ ID NO: 1; and (ii) a polypeptide comprising the amino acid sequence of SEQ ID NO: 9.
Patent NZ-749585-A (NZ)
Title: Herv-e reactive t cell receptors and methods of use
Inventor: CHILDS RICHARD W
IPC: C12N15/85
Filed: 2017-06-30
Abstract: Disclosed herein are T cell receptors (TCRs) capable of binding an antigen expressed by renal cell carcinoma cells. In some examples, the TCRs include an a chain (such as SEQ ID NO: 2) and a β chain (such as SEQ ID NO: 3). Also disclosed herein are vectors including nucleic acids encoding the disclosed TCR a and/or β chains. Further disclosed are modified T cells expressing the TCRs. In some examples, the modified T cells are prepared by transducing T cells with a vector including nucleic acids encoding the TCR a chain and the TCR β chain. In some embodiments, methods include treating a subject with RCC, by obtaining a population of T cells, transducing the population of T cells with a vector including a nucleic acids encoding the TCR a chain and the TCR β chain, and administering a composition comprising the modified T cells to the subject.